PrimeRFP SCOUT · Federal Contract Recompete Brief

W81XWH19C0193Analgesic ketamine-clinical TRIAL — Emergent Product Development Gaithersburg Inc

Emergent Product Development Gaithersburg Inc holds $446.6M across 7 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: NONE. Recompete timing centers on the Nov 19, 2026 PoP end — agencies typically plan 12–18 months ahead.

W4pz Usa Med Rsch Acquis Act
Awarding office
Emergent Product Development Gaithersburg Inc
Recipient
Nov 19, 2026
PoP end
$-5,338,949.19
Obligated
541715
NAICS
AN93
PSC
NONE
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

NONE
Contract numberW81XWH19C0193
Also listed asW81XWH-19-C-0193
AgencyW4pz Usa Med Rsch Acquis Act
Awarding officeW4pz Usa Med Rsch Acquis Act
IncumbentEmergent Product Development Gaithersburg Inc
UEICNPVCR8DK7M8
NAICS541715
PSCAN93
Place of performanceGAITHERSBURG, MD
Related solicitationW81XWH19R0032
PoP end (current)Nov 19, 2026
Obligated$-5,338,949.19

ANALGESIC KETAMINE-CLINICAL TRIAL is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Emergent Product Development Gaithersburg Inc. Estimated value $26.9M ($-5,338,949.19 obligated). Current period of performance ends Nov 19, 2026. Last award drew 1 bidder. Place of performance: GAITHERSBURG, MD. Related solicitation W81XWH19R0032.

Recompete timing

Public
● Expiring in 53 days

Current PoP ends Nov 19, 2026 (53 days remaining). Agencies typically plan 12–18 months ahead — at 1.7 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on W81XWH19C0193? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Emergent Product Development Gaithersburg Inc — $446.6M obligated across 7 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)
Department of Health and Human Services (HHS)$451.9M · 100% of firm total
Open full company profile →

Related awards

Same incumbent
HHSO100201600030C
EMERGENT AV7909 ANTHRAX VACCINE
$1.4B
Sep 29, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract W81XWH19C0193?

W81XWH19C0193 (Analgesic ketamine-clinical TRIAL) is a W4pz Usa Med Rsch Acquis Act award with an estimated value of $26.9M, currently held by Emergent Product Development Gaithersburg Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is W81XWH-19-C-0193?

W81XWH-19-C-0193 is the dashed form of PIID W81XWH19C0193 (Analgesic ketamine-clinical TRIAL), held by Emergent Product Development Gaithersburg Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded W81XWH19C0193?

W4pz Usa Med Rsch Acquis Act awarded W81XWH19C0193 to Emergent Product Development Gaithersburg Inc.

Who is the incumbent on W81XWH19C0193?

Emergent Product Development Gaithersburg Inc is the incumbent with $446.6M across 7 related awards in SCOUT’s public footprint. The current period of performance ends Nov 19, 2026.

When does Emergent Product Development Gaithersburg Inc’s W81XWH19C0193 come up for recompete?

SCOUT tracks a period-of-performance end of Nov 19, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on W81XWH19C0193? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/W81XWH19C0193